Deutsche Bank
STRO icon

Deutsche Bank’s Sutro Biopharma STRO Stock Holding History

Deutsche Bank’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-4,253
Closed -$147K – 3700
2024
Q3 		$147K Buy
4,253
+1,435
+51% +$56.3K ﹤0.01% 3068
2024
Q2 		$82.6K Sell
2,818
-561
-17% -$22.2K ﹤0.01% 3175
2024
Q1 		$191K Buy
3,379
+122
+4% +$5.39K ﹤0.01% 2844
2023
Q4 		$140K Sell
3,257
-121
-4% -$3.84K ﹤0.01% 3061
2023
Q3 		$117K Buy
3,378
+585
+21% +$25.5K ﹤0.01% 3083
2023
Q2 		$130K Sell
2,793
-495
-15% -$24.6K ﹤0.01% 3133
2023
Q1 		$152K Buy
3,288
+1,000
+44% +$63.5K ﹤0.01% 3133
2022
Q4 		$185K Buy
2,288
+517
+29% +$35.9K ﹤0.01% 3022
2022
Q3 		$98K Sell
1,771
-294
-14% -$17.4K ﹤0.01% 3330
2022
Q2 		$108K Sell
2,065
-314
-13% -$17.5K ﹤0.01% 3492
2022
Q1 		$195K Sell
2,379
-3,336
-58% -$317K ﹤0.01% 3283
2021
Q4 		$850K Buy
5,715
+140
+3% +$25.1K ﹤0.01% 2537
2021
Q3 		$1.05M Sell
5,575
-80
-1% -$15.2K ﹤0.01% 2572
2021
Q2 		$1.05M Sell
5,655
-6,026
-52% -$1.18M ﹤0.01% 2736
2021
Q1 		$2.66M Sell
11,681
-8
-0.1% -$1.9K ﹤0.01% 1957
2020
Q4 		$2.54M Buy
11,689
+10,274
+726% +$1.7M ﹤0.01% 1780
2020
Q3 		$143K Buy
1,415
+593
+72% +$56K ﹤0.01% 3388
2020
Q2 		$64K Buy
822
+484
+143% +$46.4K ﹤0.01% 3690
2020
Q1 		$34K Sell
338
-418
-55% -$43.9K ﹤0.01% 3722
2019
Q4 		$82K Buy
756
+470
+164% +$48.5K ﹤0.01% 3677
2019
Q3 		$25K Sell
286
-605
-68% -$61.1K ﹤0.01% 4244
2019
Q2 		$100K Sell
891
-44
-5% -$4.85K ﹤0.01% 4209
2019
Q1 		$105K Sell
935
-47
-5% -$4.89K ﹤0.01% 4288
2018
Q4 		$87K Buy
+982
New +$119K ﹤0.01% 4280

Other funds holding STRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Deutsche Bank's STRO Position: Q4 2024 in Review

Deutsche Bank sold out of Sutro Biopharma (STRO) in Q4 2024, closing a stake of 4,253 shares — an estimated $147K sold.

Deutsche Bank first reported a position in STRO in Q4 2018 and held it in 24 quarters. The position peaked at $2.66M in Q1 2021. 122 funds tracked by Wall St. Rank hold STRO as of Q4 2024.

  • Deutsche Bank reported no remaining Sutro Biopharma position as of Q4 2024 after selling out during the quarter.
  • Deutsche Bank sold 4,253 Sutro Biopharma shares in Q4 2024, an estimated $147K.
  • Deutsche Bank first reported a position in Sutro Biopharma in Q4 2018 and held it in 24 quarters.
  • Deutsche Bank's Sutro Biopharma position peaked at $2.66M in Q1 2021.
  • 122 funds tracked by Wall St. Rank held Sutro Biopharma as of Q4 2024.

Based on Deutsche Bank's 13F filing for Q4 2024, filed 14 Feb 2025.